ABBV-969

· AbbVie

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABBV-969, covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer [Phase 1]

See pricing